▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Brian Feroldi

TMFTypeoh

Brian Feroldi has been covering the healthcare and technology industries for The Motley Fool since 2015. Brian's investing strategy is to buy high-quality companies and then let compounding work its magic. See all of his articles here.

Recent Articles by Brian Feroldi

Photo by familytreasures Flickr Creative Commons

Sep 26, 2015 by Brian Feroldi, Selena Maranjian, and Matt Frankel

Don't Delay: Consider Making These Money Moves for Your Kids Today

Thinking about giving your kids a financial leg up in life? You should consider using our tips to get the ball rolling today.

Image by GotCredit.com : Flickr Creative Commons

Sep 26, 2015 by Brian Feroldi, Todd Campbell, and George Budwell

3 Stocks We're Ready to Sell

When the market gets choppy, it can be a good time take a hard look at your portfolio.

Sep 25, 2015 by Brian Feroldi

Why bluebird bio Inc Shares Slumped Again

On a bad day for biotech stocks, bluebird bio gets shot down.

Boston

Sep 25, 2015 by Brian Feroldi

A Double Dose of Good News for Vertex Pharmaceuticals Incorporated Investors

A European committee adopts a positive view of Vertex's drugs, and the opportunity looks huge for investors.

Sep 25, 2015 by Brian Feroldi

The Price War for New Cholesterol Drugs Is Heating Up

Exciting new LDL-cholesterol-lowering medication offers a lot of hope for patients with high cholesterol, but a new report says they're priced far too high to be cost-effective.

Image by Pictures of Money Flickr Creative Commons3

Sep 25, 2015 by Brian Feroldi, Todd Campbell, George Budwell, and Adam Galas

Easy Ways to Improve Your Financial Future Right Now

Looking to shore up your financial picture? Here are our top ideas that you can use to ensure a bright financial future.

Phot by Beximco Pharma Flickr Creative Commons

Sep 25, 2015 by Brian Feroldi, Todd Campbell, and George Budwell

3 Mid-Cap Biotechs We're Excited About

Our healthcare contributors think you should add these mid-cap biotechs to your watch list.

Sep 24, 2015 by Brian Feroldi

Keryx Biopharmaceuticals Grabs an Important Approval

Shares of the beaten-down biopharmaceutical company bounce back on the heels of an overseas approval. What does this news mean for long term investors?

Sep 23, 2015 by Brian Feroldi

Why BioMed Realty Trust Inc is Moving Higher Today

Reports that the company is looking for a buyout caused its stock to spike.

Sep 21, 2015 by Brian Feroldi

Did Hillary Clinton Cause bluebird bio to Slump Today?

The presidential candidate's tweet takes down the entire biotech sector, and bluebird gets caught up in the action.

Gilead1

Sep 21, 2015 by Brian Feroldi, Todd Campbell, and George Budwell

Here's Why Gilead Sciences Is a Buy (Hint: It's Not Hepatitis C)

Gilead's Hepatitis C treatments Sovaldi and Harvoni tend to grab all the headlines, but here are 3 other reasons that we Fools think Gilead is a top choice.

Image by Pictures of Money Flickr Creative Commons

Sep 19, 2015 by Brian Feroldi

3 Triple-Digit Biotech Stocks That Are Worth Every Penny

Are you reluctant to invest in stocks trading for over $100? You shouldn't be. Here are three high-quality biotech names that you should consider.

Alexion Pharmaceuticals

Sep 18, 2015 by Brian Feroldi, Todd Campbell, and George Budwell

3 Biotech Stocks That Can Upgrade Your Portfolio

Are you looking to add some biotech exposure to your portfolio, but want to stick with the stronger names in the group? Our Motley Fool contributors have three names you should strongly consider.

Photo by StockMonkeys.com Flickr creative commons

Sep 18, 2015 by Brian Feroldi, Todd Campbell, and George Budwell

3 Investing Myths, Debunked!

Don't be fooled by these common stock market misconceptions

Photo by hobvias sudoneighm Flickr Creative Commons

Sep 18, 2015 by Brian Feroldi, Todd Campbell, and George Budwell

Our Top Investing Regrets

Everybody makes mistakes when they are investing; we Fools are no different.

Image by Tax Credits Flickr Creative Commons

Sep 18, 2015 by Brian Feroldi

3 Healthcare Stocks That Cost Less Than a Trip to Chipotle

A quick trip to Chipotle will set you back about $10. Instead of using that money to buy a delicious burrito, consider these tasty stocks.

Photo by epSos .de Flickr Creative Commons

Sep 18, 2015 by Brian Feroldi, Joe Tenebruso, Todd Campbell, George Budwell, and Adam Galas

5 Time-Saving Investing Tips

Investing smartly can require a lot of time, but that doesn't there aren't ways to speed up the process. Here are three time-saving tips that may help you become a better investor.

Photo by Images_of_Money : Flickr Creative Commons

Sep 16, 2015 by Brian Feroldi, Todd Campbell, and George Budwell

3 Healthcare Stocks That Could Add a Spark to Your Portfolio

Looking to give your portfolio a jolt? Consider investing in these three spicy healthcare names.

Gilead

Sep 16, 2015 by Brian Feroldi

5 Reasons I'm Buying More Gilead Sciences Inc.

The company gets stronger, and the price has gone nowhere. I'm back for a second helping.

intuitive surgiical 2

Sep 15, 2015 by Brian Feroldi, Todd Campbell, and George Budwell

3 MedTech Stocks to Sprinkle Into Your Portfolios

What medical device stocks do our contributors think could add some spice to your portfolio right now?

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services